Szemészet, 2015 (152. évfolyam, 1-4. szám)

2015-12-01 / 4. szám

Salzmann-féle nodulánis degeneráció

Irodalom

1. Abbott RL, Forster RK. Superficial punctate keratitis of Thygeson associated with scarring and Salzmann's nodular degeneration. Am J Ophthalmol 1979; 87: 296-298.

2. Al-Fawaz A, Wagoner MD. Penetrating Keratoplasty for Trachomatous Corneal Scarring. Cornea 2008; 27: 129-132.

3. Ballintine EJ, Rotbart DC, Takimura Y. Phlyctenulosis. Am J Ophthalmol 1972; 73: 459-460.

4. Bowers PJ, Jr., Price MO, Zeldes SS, Price FW, Jr. Superficial keratectomy with mitomycin-C for the treatment of Salzmann's nodules. J Cat Refr Surg 2003; 29: 1302-1306.

5. Chihaia MA, Bohringer D, Eberwein R Reinhard T. Re: Peripheral hypertrophic subepithelial corneal degeneration - clinical and histopathological features. Acta Ophthalmol 2015; DOT. 10.1111/aos. 12712.

6. Das S, Langenbucher A, Pogorelov R Link B, Seitz B. Long-term outcome of excimer laser phototherapeutic keratectomy for treatment of Salzmann's nodular degeneration. J Cat Refr Surg 2005; 31: 1386-1391.

7. Das S, Link B, Seitz B. Salzmann's nodular degeneration of the cornea: a review and case series. Cornea 2005; 24: 772-777.

8. Duke-Elder S. System of Ophthalmology, vol. VIII. Diseases of the outer eye, part 2 Cornea. In: Duke-Elder S, Leigh AG CHrsg] Salzmann's nodular degeneration. London: Kimpton; 1965, p. 904-907.

9. Eberwein R Hiss S, Auw-Haedrich C, et al. Epithelial marker expression in Salzmann nodular degeneration shows characteristics of limbal transient amplifying cells and alludes to an involvement of the epithelium in its pathogenesis. Acta Ophthalmol 2010; 88:184-189.

10. Eberwein R Reinhard T, Sundmacher R. Re: Gore, et al. Peripheral hypertrophic subepithelial corneal degeneration: nomenclature, phenotypes, and long-term outcomes (Ophthalmology 2013; 120: 892-8). Ophthalmology 2014; 121: 23.

11. Farjo AA, Halperin Gl, Syed N, Sutphin JE, Wagoner MD. Salzmann's nodular corneal degeneration clinical characteristics and surgical outcomes. Cornea 2006; 25: 11-15.

12. Fong YC, Chuck RS, Stark WJ, McOonnell PJ. Phototherapeutic keratectomy for superficial corneal fibrosis after radial keratotomy. J Cat Refr Surg 2000; 26: 616-619.

13. Fuchs E. Über knöthchenförmige Hornhautrübung. Graefes Arch Ophthalmol 1901; 53: 423-438.

14. Gatzioufas Z, Hager T, El-Husseiny M, Kozeis N, Seitz B. Salzmann's nodular degeneration on a corneal graft 20 years after penetrating keratoplasty for keratoconus. Ophthalmologe 2011; 108: 963-965.

15. Germundsson J, Fagerholm P Phototherapeutic keratectomy in Salzmann's nodular degeneration. Acta Ophthalmol Scand 2004; 82: 148-153.

16. Gore DM, lovieno A, Connell BJ, et al. Peripheral hypertrophic subepithelial corneal degeneration: nomenclature, phenotypes, and long-term outcomes. Ophthalmology 2013; 120: 892-898.

17. Graue-Hernandez EO, Mannis MJ, Eliasieh K, et al. Salzmann nodular degeneration. Cornea 2010; 29: 283-289.

18. Hinzpeter EN, Naumann GOH. Hornhaut und Sklera. In: Naumann GOH, editor Pathologie des Auges. Berlin: Springer; 1980. p. 313-407.

19. Hurmeric V, Yoo SH, Karp CL, et al. In vivo morphologic characteristics of Salzmann nodular degeneration with ultra-high-resolution optical coherence tomography. Am J Ophthalmol 2011; 151: 248-256.

20. Jarventausta PJ, Holopainen JM, Zalentein WN, et al. Peripheral hypertrophic subepithelial corneal degeneration: characterization, treatment and association with human leucocyte antigen genes. Acta Ophthalmol 2014; 92: 71-76.

21. Jarventausta PJ, Tervo TM, Kivela T, Holopainen JM. Peripheral hypertrophic subepithelial corneal degeneration - clinical and histopathological features. Acta Ophthalmol 2014; 92: 774-782.

22. Khaireddin R, Katz T, Baile RB, Richard G, Linke SJ. Superficial keratectomy, PTK, and mitomycin C as a combined treatment option for Salzmann's nodular degeneration: a follow-up of eight eyes.

Graefes Arch Clin Exp Ophthalmol 2011; 249: 1211-1215.

23. Ku JY, Grupcheva CN, McGhee CN. Microstructural analysis of Salzmann's nodular degeneration by in vivo confocal microscopy. Clin Experiment Ophthalmol 2002; 30: 367-368.

24. Lim MC, Chan WK. Salzmann nodular degeneration after laser in situ keratomileusis. Cornea 2009; 28: 577-578.

25. Maloney RK, Thompson V, Ghiselli G, et al. A prospective multicenter trial of excimer laser phototherapeutic keratectomy for corneal vision loss. The Summit Phototherapeutic Keratectomy Study Group. Am J Ophthalmol 1996; 122: 149-160.

26. Marcon AS, Rapuano CJ. Excimer laser phototherapeutic keratectomy retreatment of anterior basement membrane dystrophy and Salzmann's nodular degeneration with topical mitomycin C. Cornea 2002; 21: 828-830.

27. Mathers WD, Stovall D, Lane JA, et al. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea 1998; 17: 353-358.

28. Meltendorf C, Bühren J, Bug R, Ohrloff C, Kohnen T. Correlation between clinical in vivo confocal microscopic and ex vivo histopathologic findings of Salzmann nodular degeneration. Cornea 2006; 25: 734-738.

29. Oster JG, Steinert RE Hogan RN. Reduction of hyperopia associated with manual excision of Salzmann's nodular degeneration. J Refract Surg 2001; 17: 466-469.

30. Papanikolaou T, Goel S, Jayamanne DG, et al. Familial pattern of Salzmann-type nodular corneal degeneration—a four generation series. Br J Ophthalmol 2010; 94: 1543.

31. Nagy ZZ, Krueger RR, Süveges I. Central bump-like opacity as a complication of high hyperopic photorefractive keratectomy. Am J Ophtalmol 1999; 128:636-638.

32. Reddy JC, Rapuano CJ, Felipe AE et al. Quality of vision after excimer laser phototherapeutic keratectomy with intraoperative mitomycin-C for Salzmann nodular degeneration. Eye Contact Lens 2014; 40: 213-219.

33. Rodrigues MM, Krachmer JH. Recent advances in corneal stromal dystrophies. Cornea 1988; 7: 19-29.

34. Salzmann M. Über eine Abart der Knötchenförmigen Hornhaut- Dystrophie. Z Augenheilkd 1925; 57: 92-99.

35. Schragus M, Kusserow C, Schlötzer-Schrehardt U, et al. Peripheral hypertrophic subepithelial corneal degeneration presenting with bilateral nasal and temporal corneal changes. Eye 2015; 29: 88-97.

36. Severin M, Kirchhof В. Recurrent Salzmann's corneal degeneration. Graefes Arch Clin Exp Ophthalmol 1990; 228: 101-104.

37. Singer AR, Pahl S, Lang HM, Ruprecht KW. A familial anterior corneal degeneration: clinical aspects, histopathology and differential diagnosis. Klin Monbl Augenheilkd 1998; 213: 104-107.

38. Stone DU, Astley RA, Shaver RR Chodosh J. Histopathology of Salzmann nodular corneal degeneration. Cornea 2008; 27:148-151,

39. Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sei 2002; 966: 211-222.

40. Sundmacher R. Salzmann's nodular degeneration. Mostly an epithelial corneal dystrophy. Ophthalmologe 2012; 109: 389-403.

41. Süveges I. A szaruhártya (corneal betegségei. In: Süveges I, ed. Szemészet 4th ed. Budapest: Medicina; 2015. p. 119-150.

42. Teus MA, de Benito-Llopis L, Alio JL. Mitomycin C in corneal refractive surgery. Surv Ophthalmol 2009; 54: 487-502.

43. VanderBeek BL, Silverman RH, Starr CE. Bilateral Salzmann-like nodular corneal degeneration after laser in situ keratomileusis imaged with anterior segment optical coherence tomography and high-frequency ultrasound bio-microscopy. J Cataract Refract Surg 2009; 35: 785-787.

44. Vannas A, Hogan MJ, Wood I. Salzmann's nodular degeneration of the cornea. Am J Ophthalmol 1975; 79: 211-219.

45. Wood TO. Salzmann's nodular degeneration. Cornea 1990; 9: 17-22.

Levelezési cím

Dr. Tóth Gábor, 1085 Budapest, Mária u. 39. E-mail: gabortothgabor@gmail.com

i 199;